Savla, Jainy J., Benjamin D. Levine, and Hesham A. Sadek. The effect of hypoxia on cardiovascular disease: Friend or foe? High Alt Med Biol. 19:124–130, 2018.—Over 140 million people reside at altitudes exceeding 2500 m across the world, resulting in exposure to atmospheric (hypobaric) hypoxia. Whether this chronic exposure is beneficial or detrimental to the cardiovascular system, however, is uncertain. On one hand, multiple studies have suggested a protective effect of living at moderate and high altitudes for cardiovascular risk factors and cardiovascular disease (CVD) events. Conversely, residence at high altitude comes at the tradeoff of developing diseases such as chronic mountain sickness and high-altitude pulmonary hypertension and worsens outcomes for diseases such as chronic obstructive pulmonary disease. Interestingly, recently published data show a potential role for severe hypoxia as a unique and unexpected therapy after myocardial infarction. In this review, we will discuss the current literature evaluating the effects of altitude exposure and the accompanying hypoxia on health and the potential therapeutic applications of hypoxia on CVD.
Get full access to this article
View all access options for this article.
References
1.
Al-HuthiMA, Raja'aYA, Al-NoamiM, and Abdul RahmanAR. (2006). Prevalence of coronary risk factors, clinical presentation, and complications in acute coronary syndrome patients living at high vs low altitudes in Yemen. MedGenMed, 8:28.
2.
Al RiyamiNB, BanerjeeY, Al-WailiK, RizviSG, Al-YahyaeeS, HassanMO, AlbarwaniS, Al-RasadiK, and BayoumiRA. (2015). The effect of residing altitude on levels of high-density lipoprotein cholesterol: A pilot study from the Omani Arab population. Angiology, 66:568–573.
3.
al TahanA, BuchurJ, el KhwskyF, OgunniyiA, al-RajehS, LarbiE, DaifA, and BamgboyeE. (1998). Risk factors of stroke at high and low altitude areas in Saudi Arabia. Arch Med Res, 29:173–177.
4.
AlexanderJK, HartleyLH, ModelskiM, and GroverRF. (1967). Reduction of stroke volume during exercise in man following ascent to 3,100 m altitude. J Appl Physiol, 23:849–858.
5.
Arbab-ZadehA, LevineBD, TrostJC, LangeRA, KeeleyEC, HillisLD, and CigarroaJE. (2009). The effect of acute hypoxemia on coronary arterial dimensions in patients with coronary artery disease. Cardiology, 113:149–154.
6.
AryalN, WeatherallM, BhattaYK, and MannS. (2016). Blood pressure and hypertension in adults permanently living at high altitude: A systematic review and meta-analysis. High Alt Med Biol, 17:185–193.
7.
AuroraAB, PorrelloER, TanW, MahmoudAI, HillJA, Bassel-DubyR, SadekHA, and OlsonEN. (2014). Macrophages are required for neonatal heart regeneration. J Clin Invest, 124:1382–1392.
8.
BaggishAL, WolfelEE, and LevineBD. (2014). The Cardiovascular System at High Altitude. Springer Publications, New York.
9.
BaibasN, TrichopoulouA, VoridisE, and TrichopoulosD. (2005). Residence in mountainous compared with lowland areas in relation to total and coronary mortality. A study in rural Greece. J Epidemiol Community Health, 59:274–278.
10.
BartschP, SaltinB, DvorakJ; Federation Internationale de Football Association. (2008). Consensus statement on playing football at different altitude. Scand J Med Sci Sports, 18 (Suppl 1):96–99.
11.
BayramF, KocerD, GundoganK, KayaA, DemirO, CoskunR, SabuncuT, KaramanA, CesurM, RizzoM, et al. (2014). Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidol, 8:206–216.
12.
BeallCM. (2000). Tibetan and Andean patterns of adaptation to high-altitude hypoxia. Hum Biol, 72:201–228.
13.
BenderPR, GrovesBM, McCulloughRE, McCulloughRG, HuangSY, HamiltonAJ, WagnerPD, CymermanA, and ReevesJT. (1988). Oxygen transport to exercising leg in chronic hypoxia. J Appl Physiol (1985), 65:2592–2597.
14.
BenzigerCP, Bernabe-OrtizA, GilmanRH, CheckleyW, SmeethL, MalagaG, MirandaJJ; CRONICAS Cohort Study Group. (2015). Metabolic abnormalities are common among South American Hispanics subjects with normal weight or excess body weight: The CRONICAS cohort study. PLoS One, 10:e0138968.
15.
Bernabe-OrtizA, Carrillo-LarcoRM, GilmanRH, CheckleyW, SmeethL, Miranda JJ; CRONICAS Cohort StudyGroup. (2017). Impact of urbanisation and altitude on the incidence of, and risk factors for, hypertension. Heart, 103:827–833.
16.
BristowMR, GinsburgR, MinobeW, CubicciottiRS, SagemanWS, LurieK, BillinghamME, HarrisonDC, and StinsonEB. (1982). Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med, 307:205–211.
17.
BritoJ, SiquesP, Leon-VelardeF, De La CruzJJ, LopezV, and HerruzoR. (2007). Chronic intermittent hypoxia at high altitude exposure for over 12 years: Assessment of hematological, cardiovascular, and renal effects. High Alt Med Biol, 8:236–244.
18.
BryantDM, O'MearaCC, HoNN, GannonJ, CaiL, and LeeRT. (2015). A systematic analysis of neonatal mouse heart regeneration after apical resection. J Mol Cell Cardiol, 79:315–318.
19.
BuchJ, EgebladH, HansenPB, KjaergardH, WaldorffS, and SteinessE. (1980). Correlation between changes in systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Non-invasive monitoring of pharmacological intervention. Br Heart J, 44:668–671.
20.
DarehzereshkiA, RubinN, GambaL, KimJ, FraserJ, HuangY, BillingsJ, MohammadzadehR, WoodJ, WarburtonD, et al. (2015). Differential regenerative capacity of neonatal mouse hearts after cryoinjury. Dev Biol, 399:91–99.
21.
de MendozaS, NuceteH, IneichenE, SalazarE, ZerpaA, and GlueckCJ. (1979). Lipids and lipoproteins in subjects at 1,000 and 3,500 meter altitudes. Arch Environ Health, 34:308–311.
22.
Dominguez CoelloS, Cabrera De LeonA, Bosa OjedaF, Perez MendezLI, Diaz GonzalezL, and Aguirre-JaimeAJ. (2000). High density lipoprotein cholesterol increases with living altitude. Int J Epidemiol, 29:65–70.
23.
DunnA, LoV, and DonnellyS. (2007). The role of the kidney in blood volume regulation: The kidney as a regulator of the hematocrit. Am J Med Sci, 334:65–71.
24.
EzzatiM, HorwitzME, ThomasDS, FriedmanAB, RoachR, ClarkT, MurrayCJ, and HonigmanB. (2012). Altitude, life expectancy and mortality from ischaemic heart disease, stroke, COPD and cancers: National population-based analysis of US counties. J Epidemiol Community Health, 66:e17.
25.
FaehD, GutzwillerF, Bopp M; Swiss National Cohort StudyGroup. (2009). Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation, 120:495–501.
26.
FaehD, MoserA, PanczakR, BoppM, RoosliM, SpoerriA; Swiss National Cohort Study Group. (2016). Independent at heart: Persistent association of altitude with ischaemic heart disease mortality after consideration of climate, topography and built environment. J Epidemiol Community Health, 70:798–806.
27.
FioriG, FacchiniF, PettenerD, RimondiA, BattistiniN, and BedogniG. (2000). Relationships between blood pressure, anthropometric characteristics and blood lipids in high- and low-altitude populations from Central Asia. Ann Hum Biol, 27:19–28.
28.
FowlesRE, and HultgrenHN. (1983). Left ventricular function at high altitude examined by systolic time intervals and M-mode echocardiography. Am J Cardiol, 52:862–866.
29.
GinouvesA, IlcK, MaciasN, PouyssegurJ, and BerraE. (2008). PHDs overactivation during chronic hypoxia “desensitizes” HIFalpha and protects cells from necrosis. Proc Natl Acad Sci U S A, 105:4745–4750.
30.
GroverRF, LufschanowskiR, and AlexanderJK. (1976). Alterations in the coronary circulation of man following ascent to 3,100 m altitude. J Appl Physiol, 41:832–838.
31.
GrovesBM, DromaT, SuttonJR, McCulloughRG, McCulloughRE, ZhuangJ, RapmundG, SunS, JanesC, and MooreLG. (1993). Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. J Appl Physiol (1985), 74:312–318.
32.
HansenJ, and SanderM. (2003). Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol, 546:921–929.
33.
HartJ. (2015). Heart disease death rates in low versus high land elevation counties in the U.S. Dose Response 13:pii: dose-response.14-021.Hart.
34.
HirataK, BanT, JinnouchiY, and KuboS. (1991). Echocardiographic assessment of left ventricular function and wall motion at high altitude in normal subjects. Am J Cardiol, 68:1692–1697.
35.
HoonRS, BalasubramanianV, MathewOP, TiwariSC, SharmaSC, and ChadhaKS. (1977). Effect of high-altitude exposure for 10 days on stroke volume and cardiac output. J Appl Physiol Respir Environ Exerc Physiol, 42:722–727.
36.
HuH, PetousiN, GlusmanG, YuY, BohlenderR, TashiT, DownieJM, RoachJC, ColeAM, LorenzoFR, et al. (2017). Evolutionary history of Tibetans inferred from whole-genome sequencing. PLoS Genet, 13:e1006675.
37.
HuY, SunQ, LiZ, ChenJ, ShenC, SongY, and ZhongQ. (2014). High basal level of autophagy in high-altitude residents attenuates myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg, 148:1674–1680.
38.
HurtadoA, EscuderoE, PandoJ, SharmaS, and JohnsonRJ. (2012). Cardiovascular and renal effects of chronic exposure to high altitude. Nephrol Dial Transplant, 27 (Suppl 4):iv11–iv16.
39.
JainSC, BardhanJ, SwamyYV, KrishnaB, and NayarHS. (1980). Body fluid compartments in humans during acute high-altitude exposure. Aviat Space Environ Med, 51:234–236.
40.
JeffersonJA, EscuderoE, HurtadoME, KellyJP, SwensonER, WenerMH, BurnierM, MaillardM, SchreinerGF, SchoeneRB, et al. (2002). Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemia. Am J Kidney Dis, 39:1135–1142.
41.
KacimiR, RichaletJ-P, CorsiniA, AbousahlI, and CrozatierB. (1992). Hypoxia-induced downregulation of beta-adrenergetic receptors in rat heart. J Appl Physiol, 73:1377–1382.
42.
KarlinerJS, SarnquistFF, GraberDJ, PetersRMJr., and WestJB. (1985). The electrocardiogram at extreme altitude: Experience on Mt. Everest. Am Heart J, 109:505–513.
43.
KeyesLE, SalladeTD, DukeC, StarlingJ, SheetsA, PantS, YoungDS, TwillmanD, RegmiN, PhelanB, et al. (2017). Blood pressure and altitude: An observational cohort study of hypertensive and nonhypertensive Himalayan Trekkers in Nepal. High Alt Med Biol, 18:267–277.
44.
KhalidME, AliME, AhmedEK, and ElkaribAO. (1994). Pattern of blood pressures among high and low altitude residents of southern Saudi Arabia. J Hum Hypertens, 8:765–769.
45.
KlausenK. (1966). Man's acclimatization to altitude during the first week at 3.800 M. Schweiz Z Sportmed, 14:246–253.
46.
LauS, PatnaikN, SayenMR, and MestrilR. (1997). Simultaneous overexpression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury. Circulation, 96:2287–2294.
47.
LevineBD. (2015). Going high with heart disease: The effect of high altitude exposure in older individuals and patients with coronary artery disease. High Alt Med Biol, 16:89–96.
48.
LundbyC, CalbetJ, van HallG, SaltinB, and SanderM. (2018). Sustained sympathetic activity in altitude acclimatizing lowlanders and high-altitude natives. Scand J Med Sci Sports, 28:854–861.
49.
MahmoudAI, O'MearaCC, GemberlingM, ZhaoL, BryantDM, ZhengR, GannonJB, CaiL, ChoiWY, EgnaczykGF, et al. (2015). Nerves regulate cardiomyocyte proliferation and heart regeneration. Dev Cell, 34:387–399.
50.
MalconianM, RockP, HultgrenH, DonnerH, CymermanA, GrovesB, ReevesJ, AlexanderJ, SuttonJ, NittaM, et al. (1990). The electrocardiogram at rest and exercise during a simulated ascent of Mt. Everest (Operation Everest II). Am J Cardiol, 65:1475–1480.
51.
MarticorenaE, RuizL, SeverinoJ, GalvezJ, and PenalozaD. (1969). Systemic blood pressure in white men born at sea level: Changes after long residence at high altitudes. Am J Cardiol, 23:364–368.
52.
MelilloG, MussoT, SicaA, TaylorLS, CoxGW, and VaresioL. (1995). A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med, 182:1683–1693.
53.
MieleCH, SchwartzAR, GilmanRH, PhamL, WiseRA, Davila-RomanVG, JunJC, PolotskyVY, MirandaJJ, Leon-VelardeF, et al. (2016). Increased cardiometabolic risk and worsening hypoxemia at high altitude. High Alt Med Biol, 17:93–100.
54.
MingjiC, OnakpoyaIJ, PereraR, WardAM, and HeneghanCJ. (2015). Relationship between altitude and the prevalence of hypertension in Tibet: A systematic review. Heart, 101:1054–1060.
55.
MirrakhimovMM, RafibekovaZhS, DzhumagulovaAS, MeimanalievTS, MuratalievTM, and ShatemirovaKK. (1985). Prevalence and clinical peculiarities of essential hypertension in a population living at high altitude. Cor Vasa, 27:23–28.
56.
MooreLG, NiermeyerS, and ZamudioS. (1998). Human adaptation to high altitude: Regional and life-cycle perspectives. Am J Phys Anthropol Suppl, 27:25–64.
57.
MoretP, CovarrubiasE, CoudertJ, and DuchosalF. (1972). Cardiocirculatory adaptation to chronic hypoxia: Comparative study of coronary flow, myocardial oxygen consumption and efficiency between sea level and high altitude residents. Acta Cardiol, 27:283–305.
58.
MortimerEAJr., MonsonRR, and MacMahonB. (1977). Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med, 296:581–585.
59.
MyhreLG, DillDB, HallFG, and BrownDK. (1970). Blood volume changes during three-week residence at high altitude. Clin Chem, 16:7–14.
NguyenAD, McDonaldJG, BruickRK, and DeBose-BoydRA. (2007). Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of insigs. J Biol Chem, 282:27436–27446.
62.
NikinmaaM. (2002). Oxygen-dependent cellular functions—Why fishes and their aquatic environment are a prime choice of study. Comp Biochem Physiol A Mol Integr Physiol, 133:1–16.
63.
O'MearaCC, WamstadJA, GladstoneRA, FomovskyGM, ButtyVL, ShrikumarA, GannonJB, BoyerLA, and LeeRT. (2015). Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration. Circ Res, 116:804–815.
64.
OtsukaK, NorbooT, OtsukaY, HiguchiH, HayajiriM, NarushimaC, SatoY, TsugoshiT, MurakamiS, WadaT, et al. (2005). Chronoecological health watch of arterial stiffness and neuro-cardio-pulmonary function in elderly community at high altitude (3524 m), compared with Japanese town. Biomed Pharmacother, 59 (Suppl 1):S58–S67.
65.
PasiniGF, DonatoF, BuizzaMA, FantoniC, GelattiU, TaniM, and GrassiV. (1999). Prevalence of risk factors for coronary heart disease in a mountain community in northern Italy. G Ital Cardiol, 29:891–897.
66.
PolizzottiBD, GanapathyB, WalshS, ChoudhuryS, AmmanamanchiN, BennettDG, dos RemediosCG, HaubnerBJ, PenningerJM, and KuhnB. (2015). Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window. Sci Transl Med, 7:281ra45.
67.
PorrelloER, MahmoudAI, SimpsonE, HillJA, RichardsonJA, OlsonEN, and SadekHA. (2011). Transient regenerative potential of the neonatal mouse heart. Science, 331:1078–1080.
68.
PorrelloER, MahmoudAI, SimpsonE, JohnsonBA, GrinsfelderD, CansecoD, MammenPP, RothermelBA, OlsonEN, and SadekHA. (2013). Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci U S A, 110:187–192.
69.
PossKD, WilsonLG, and KeatingMT. (2002). Heart regeneration in zebrafish. Science, 298:2188–2190.
70.
ReevesJT, GrovesBM, SuttonJR, WagnerPD, CymermanA, MalconianMK, RockPB, YoungPM, and HoustonCS. (1987). Operation Everest II: Preservation of cardiac function at extreme altitude. J Appl Physiol (1985), 63:531–539.
71.
RichardsonDW, KontosHA, RaperAJ, PattersonJLJr. (1967). Modification by beta-adrenergic blockade of the circulatory respones to acute hypoxia in man. J Clin Invest, 46:77–85.
72.
SavardGK, AreskogNH, and SaltinB. (1995). Cardiovascular response to exercise in humans following acclimatization to extreme altitude. Acta Physiol Scand, 154:499–509.
73.
SemenzaGL, and WangGL. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol, 12:5447–5454.
74.
SharmaS. (1990). Clinical, biochemical, electrocardiographic and noninvasive hemodynamic assessment of cardiovascular status in natives at high to extreme altitudes (3000 m-5500 m) of the Himalayan region. Indian Heart J, 42:375–379.
75.
SharmaSC, BalasubramanianV, MathewOP, and HoonRS. (1977). Serial studies of heart rate, blood pressure and urinary catecholamine excretion on acute induction to high altitude (3658 m). Indian J Chest Dis Allied Sci, 19:16–20.
76.
SharmaSC, HoonRS, BalasubramanianV, and ChadhaKS. (1978). Urinary catecholamine excretion in temporary residents of high altitude. J Appl Physiol Respir Environ Exerc Physiol, 44:725–727.
77.
ShenY, ChangC, ZhangJ, JiangY, NiB, and WangY. (2017). Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: A cross-sectional study. Environ Health Prev Med, 22:19.
78.
SiebenmannC, and LundbyC. (2015). Regulation of cardiac output in hypoxia. Scand J Med Sci Sports, 25 (Suppl 4):53–59.
79.
SimonsonTS, YangY, HuffCD, YunH, QinG, WitherspoonDJ, BaiZ, LorenzoFR, XingJ, JordeLB, et al. (2010). Genetic evidence for high-altitude adaptation in Tibet. Science, 329:72–75.
80.
SiquesP, BritoJ, NaveasN, PulidoR, De la CruzJJ, MamaniM, and Leon-VelardeF. (2014). Plasma and liver lipid profiles in rats exposed to chronic hypobaric hypoxia: Changes in metabolic pathways. High Alt Med Biol, 15:388–395.
81.
SuarezJ, AlexanderJK, and HoustonCS. (1987). Enhanced left ventricular systolic performance at high altitude during Operation Everest II. Am J Cardiol, 60:137–142.
82.
TemteJL. (1996). Elevation of serum cholesterol at high altitude and its relationship to hematocrit. Wilderness Environ Med, 7:216–224.
83.
TuderRM, FlookBE, and VoelkelNF. (1995). Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest, 95:1798–1807.
84.
VillafuerteFC. (2015). New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness. J Appl Physiol (1985), 119:1481–1486.
85.
VogelJA, HansenJE, and HarrisCW. (1967). Cardiovascular responses in man during exhaustive work at sea level and high altitude. J Appl Physiol, 23:531–539.
86.
VogelJA, HartleyLH, and CruzJC. (1974). Cardiac output during exercise in altitude natives at sea level and high altitude. J Appl Physiol, 36:173–176.
87.
VossJD, AllisonDB, WebberBJ, OttoJL, and ClarkLL. (2014). Lower obesity rate during residence at high altitude among a military population with frequent migration: A quasi experimental model for investigating spatial causation. PLoS One, 9:e93493.
88.
WinkelmayerWC, HurleyMP, LiuJ, and BrookhartMA. (2012). Altitude and the risk of cardiovascular events in incident US dialysis patients. Nephrol Dial Transplant, 27:2411–2417.
89.
WolfelEE, GrovesBM, BrooksGA, ButterfieldGE, MazzeoRS, MooreLG, SuttonJR, BenderPR, DahmsTE, McCulloughRE, et al. (1991). Oxygen transport during steady-state submaximal exercise in chronic hypoxia. J Appl Physiol (1985), 70:1129–1136.
90.
WolfelEE, SellandMA, CymermanA, BrooksGA, ButterfieldGE, MazzeoRS, GroverRF, and ReevesJT. (1998). O2 extraction maintains O2 uptake during submaximal exercise with beta-adrenergic blockade at 4,300 m. J Appl Physiol (1985), 85:1092–1102.
91.
WolfelEE, SellandMA, MazzeoRS, and ReevesJT. (1994). Systemic hypertension at 4,300 m is related to sympathoadrenal activity. J Appl Physiol (1985), 76:1643–1650.
92.
WoolcottOO, CastilloOA, GutierrezC, ElashoffRM, StefanovskiD, and BergmanRN. (2014). Inverse association between diabetes and altitude: A cross-sectional study in the adult population of the United States. Obesity (Silver Spring), 22:2080–2090.
93.
WozniakCJ, BairdBC, StehlikJ, DrakosSG, BullDA, PatelAN, and SelzmanCH. (2012). Improved survival in heart transplant patients living at high altitude. J Thorac Cardiovasc Surg, 143:735–741.e1.
94.
WyssCA, KoepfliP, FretzG, SeebauerM, SchirloC, and KaufmannPA. (2003). Influence of altitude exposure on coronary flow reserve. Circulation, 108:1202–1207.
95.
XiaoQ, ZhangG, WangH, ChenL, LuS, PanD, LiuG, and YangZ. (2017). A p53-based genetic tracing system to follow postnatal cardiomyocyte expansion in heart regeneration. Development, 144:580–589.
96.
XinM, KimY, SutherlandLB, MurakamiM, QiX, McAnallyJ, PorrelloER, MahmoudAI, TanW, SheltonJM, et al. (2013). Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A, 110:13839–13844.
97.
YueL, FanZ, SunL, FengW, and LiJ. (2017). Prevalence of essential hypertension and its complications among Chinese Population at high altitude. High Alt Med Biol, 18:140–144.
98.
ZaobornyjT, ValdezLB, IglesiasDE, GascoM, GonzalesGF, and BoverisA. (2009). Mitochondrial nitric oxide metabolism during rat heart adaptation to high altitude: Effect of sildenafil, L-NAME, and L-arginine treatments. Am J Physiol Heart Circ Physiol, 296:H1741–H1747.
99.
ZimmermanLH, LevineRA, and FarberHW. (1991). Hypoxia induces a specific set of stress proteins in cultured endothelial cells. J Clin Invest, 87:908–914.
